European Case Law Identifier: | ECLI:EP:BA:2003:T039702.20031010 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 10 October 2003 | ||||||||
Case number: | T 0397/02 | ||||||||
Application number: | 91903051.0 | ||||||||
IPC class: | C12N 15/67 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Endogenous gene expression modification with regulatory element by way of homologous recombination | ||||||||
Applicant name: | Applie Research Systems ARS Holding N.V. | ||||||||
Opponent name: | Gruppo Lepetit SpA Cell Genesys, Inc. |
||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Late-filed documents - criteria for admission of some into proceedings Sufficiency of disclosure - main and first auxiliary requests - no Added subject-matter - second auxiliary request - yes Clarity - second auxiliary request - no Reimbursement of the appeal fee paid by the Intervener - yes |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020397eu1.html
Date retrieved: 17 May 2021